Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen

Clinical trial NCT05088226 · RECRUITING

Trial details

NCT number: NCT05088226
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral Blood Stem Cell Transplantation

Start date: 2021-12-01
Primary completion: 2030-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.